News | Analytics Software

As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73 percent of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.

Home February 01, 2017
Home
Webinar | Inventory Management

How healthy is your cath lab supply chain? Do you struggle with managing inventory across your cath lab supply chain? It ...

Home February 01, 2017
Home
News | Structural Heart Occluders

Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer PFO Occluder. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.

Home February 01, 2017
Home
Videos | EP Mapping and Imaging Systems

This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system. It was cleared by ...

Home February 01, 2017
Home
Technology | EP Mapping and Imaging Systems

February 1, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight ...

Home February 01, 2017
Home
News | Cardiac Diagnostics

A new national survey by Orlando Health found that most women are unaware of the age at which heart screenings should begin. The American Heart Association recommends women begin undergoing regular heart screenings at age 20, but the survey found the majority of women, 60 percent, thought screenings didn't need to begin until after age 30, at least a full decade later.

Home January 31, 2017
Home
News | ECG

Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement offering. The offering was significantly over-subscribed and provides HTL with a strong financial base entering into 2017. The company expects to commence the international launch of its MyoVista product in the first quarter.

Home January 31, 2017
Home
News | Congenital Heart

To save the life of an 11-year-old boy, Ann & Robert H. Lurie Children’s Hospital of Chicago has become the first pediatric hospital in the United States to implant the 50cc SynCardia temporary Total Artificial Heart.

Home January 31, 2017
Home
News | Cardiovascular Business

Cigna and HeartWell LLP have launched a program to improve quality and cost of care for people diagnosed with chronic coronary artery disease.

Home January 31, 2017
Home
Technology | Stent Grafts

W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received U.S. Food & Drug Administration (FDA) approval for treatment of de novo or restenotic lesions found in iliac arteries. The approval includes lesions at the aortic bifurcation. This marks the availability of the only balloon expandable stent graft with an indication for the iliac artery.

Home January 31, 2017
Home
News | Dave Fornell

January 31, 2017 — The American College of Cardiology (ACC) issued a statement against President Donald Trump’s recent ...

Home January 31, 2017
Home
News | Vascular Access

January 31, 2017 — Bard Peripheral Vascular Inc. is recalling the Halo One Thin-Walled Guiding Sheath because the sheath ...

Home January 31, 2017
Home
Sponsored Content | Whitepapers | Inventory Management

Annual waste for high-value medical devices continues to grow at a rapid pace. With bundled payments putting increased ...

Home January 31, 2017
Home
cardiology Inventory management
Feature | Inventory Management | Dave Fornell

Computerized and semi-automated inventory control system technology offers a more efficient way for cardiovascular departments, especially catheterization and electrophysiology (EP) labs, to track what is on their shelves. These systems can help re-order supplies, track the department’s actual costs per procedure and identify new ways to cut costs.

Home January 31, 2017
Home
News | Contrast Media

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were published online in Annals of Emergency Medicine ("Risk of Acute Kidney Injury Following Intravenous Contrast Media Administration").

Home January 30, 2017
Home
Subscribe Now